X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (30) 30
physics (30) 30
high energy physics - experiment (28) 28
particle physics (27) 27
physics - high energy physics - experiment (25) 25
hep (23) 23
physics of elementary particles and fields (23) 23
physics, particles & fields (22) 22
fysik (20) 20
natural sciences (20) 20
naturvetenskap (20) 20
physical sciences (20) 20
ex (19) 19
物理学 (19) 19
hadron-hadron scattering (18) 18
high energy physics (15) 15
humans (15) 15
cern lhc coll (13) 13
elementary particles, quantum field theory (13) 13
quantum field theories, string theory (13) 13
large hadron collider (12) 12
index medicus (11) 11
phenomenology (11) 11
experimental results (10) 10
p p: scattering (10) 10
subatomic physics (10) 10
subatomär fysik (10) 10
aged (9) 9
middle aged (9) 9
p p: colliding beams (9) 9
particle collisions (9) 9
parton distributions (9) 9
quarks (8) 8
standard model (8) 8
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (7) 7
abridged index medicus (7) 7
astronomy & astrophysics (7) 7
astronomy, astrophysics and cosmology (7) 7
classical and quantum gravitation, relativity theory (7) 7
female (7) 7
male (7) 7
quantum physics (7) 7
top physics (7) 7
13000 gev-cms (6) 6
collisions (6) 6
diabetes (6) 6
luminosity (6) 6
measurement science and instrumentation (6) 6
nuclear energy (6) 6
nuclear physics, heavy ions, hadrons (6) 6
transverse momentum (6) 6
atlas (5) 5
cardiac & cardiovascular systems (5) 5
cardiovascular (5) 5
data analysis method (5) 5
decay (5) 5
diabetes mellitus, type 2 - drug therapy (5) 5
higgs bosons (5) 5
leptons (5) 5
nuclear and particle physics. atomic energy. radioactivity (5) 5
pp collisions (5) 5
searching (5) 5
type 2 diabetes (5) 5
acute coronary syndromes (4) 4
adult (4) 4
analysis (4) 4
cardiovascular disease (4) 4
care and treatment (4) 4
diabetes mellitus, type 2 - complications (4) 4
drug therapy (4) 4
extension (4) 4
heart attacks (4) 4
heart failure (4) 4
instruments & instrumentation (4) 4
internal medicine (4) 4
jets (4) 4
lhc (4) 4
mass (4) 4
mass dependence (4) 4
model (4) 4
nuclear experiment (4) 4
physics, nuclear (4) 4
prevention (4) 4
proton (4) 4
protons (4) 4
research (4) 4
risk factors (4) 4
squark (4) 4
7000 gev-cms8000 gev-cms (3) 3
astrophysics (3) 3
atherosclerosis (3) 3
background (3) 3
clinical trials (3) 3
collision dynamics (3) 3
computer simulation (3) 3
confidence intervals (3) 3
detectors (3) 3
distributions (3) 3
double-blind method (3) 3
events (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9982, pp. 2067 - 2076
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 169, Issue 3, pp. 305 - 314
Journal Article
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2015
Abstract Background Concerns raised regarding adverse cardiovascular (CV) outcomes with new therapies for type 2 diabetes mellitus (T2DM) have led to several... 
Cardiovascular
Journal Article
American Heart Journal, ISSN 0002-8703, 05/2016, Volume 175, pp. 18 - 27
Concerns raised regarding adverse cardiovascular (CV) outcomes with new therapies for type 2 diabetes mellitus (T2DM) have led to several large-scale CV... 
DIPEPTIDYL PEPTIDASE-4 INHIBITORS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EVENTS | MYOCARDIAL-INFARCTION | SAFETY | SAXAGLIPTIN | HEART-FAILURE | PREVENTION | DEATH | MELLITUS | Myocardial Infarction - epidemiology | Humans | Middle Aged | Hospitalization - statistics & numerical data | Myocardial Revascularization - methods | Male | Myocardial Infarction - therapy | Acute Coronary Syndrome - complications | Uracil - administration & dosage | Hypoglycemic Agents - administration & dosage | Female | Myocardial Revascularization - statistics & numerical data | Stroke - epidemiology | Myocardial Infarction - etiology | Diabetes Mellitus, Type 2 - complications | Stroke - therapy | Piperidines - administration & dosage | Risk Assessment | Standard of Care | Outcome and Process Assessment (Health Care) | Stroke - etiology | Uracil - adverse effects | Piperidines - adverse effects | Acute Coronary Syndrome - therapy | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Coronary artery bypass | Patient outcomes | Heart attack | Coronary heart disease | Studies | Heart failure | Stroke | Heart attacks | Coronary vessels | Mortality | Cardiovascular disease | Hospitalization | FDA approval | Diabetes | Acute coronary syndromes | Clinical outcomes
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article
by Aaboud, M and Aad, G and Abbott, B and Abdinov, O and Abeloos, B and Abidi, S H and AbouZeid, O S and Abraham, N L and Abramowicz, H and Abreu, H and Abreu, R and Abulaiti, Y and Acharya, B S and Adachi, S and Adamczyk, L and Adelman, J and Adersberger, M and Adye, T and Affolder, A A and Afik, Y and Agatonovic-Jovin, T and Agheorghiesei, C and Aguilar-Saavedra, J A and Ahlen, S P and Ahmadov, F and Aielli, G and Akatsuka, S and Akerstedt, H and Åkesson, T P. A and Akilli, E and Akimov, A V and Alberghi, G L and Albert, J and Albicocco, P and Alconada Verzini, M J and Alderweireldt, S C and Aleksa, M and Aleksandrov, I N and Alexa, C and Alexander, G and Alexopoulos, T and Alhroob, M and Ali, B and Aliev, M and Alimonti, G and Alison, J and Alkire, S P and Allbrooke, B M. M and Allen, B W and Allport, P P and Aloisio, A and Alonso, A and Alonso, F and Alpigiani, C and Alshehri, A A and Alstaty, M I and Alvarez Gonzalez, B and Álvarez Piqueras, D and Alviggi, M G and Amadio, B T and Amaral Coutinho, Y and Amelung, C and Amidei, D and Amor Dos Santos, S P and Amoroso, S and Amundsen, G and Anastopoulos, C and Ancu, L S and Andari, N and Andeen, T and Anders, C F and Anders, J K and Anderson, K J and Andreazza, A and Andrei, V and Angelidakis, S and Angelozzi, I and Angerami, A and Anisenkov, A V and Anjos, N and Annovi, A and Antel, C and Antonelli, M and Antonov, A and Antrim, D J and Anulli, F and Aoki, M and Aperio Bella, L and Arabidze, G and Arai, Y and Araque, J P and Araujo Ferraz, V and Arce, A T. H and Ardell, R E and Arduh, F A and Arguin, J-F and Argyropoulos, S and Arik, M and Armbruster, A J and Armitage, L J and ... and ATLAS Collaboration and The ATLAS collaboration and SLAC National Accelerator Lab., Menlo Park, CA (United States) and Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States) and Oak Ridge National Laboratory, Oak Ridge Leadership Computing Facility (OLCF) and Partikel- och astropartikelfysik and Skolan för teknikvetenskap (SCI) and KTH and Fysik
Journal of High Energy Physics, ISSN 1126-6708, 1/2018, Volume 2018, Issue 1, pp. 1 - 53
Journal Article